The first clinical application of our technology
The future of health is personal. BioTwin, a digital health technology company, is building the technology to make it possible, beginning with oncology and expanding across major areas of health.
Medical access begins in the United Arab Emirates, through participating physicians, alongside continued clinical validation.
A few drops of blood contain a complex biological story. BioTwin combines metabolomics, AI and Bio-Signatures to develop a more personal view of that story, bringing new context to cancer screening and clinical decision support.
One of the most advanced clinical applications of our technology, supported by a clinical pilot with Cleveland Clinic Abu Dhabi and a growing body of metabolic research.
A second priority application in our UAE clinical pathway. Biological insight helps clinicians explore the profile and decide what comes next.
Our first medical roadmap
Oncology leads BioTwin's next medical chapter. Our roadmap spans several medical domains, starting with cancer Bio-Signatures. Breast and colorectal cancer lead the UAE clinical pathway, while the broader program continues to develop.
Six cancer Bio-Signatures
Wellness programs are offered separately through TwinMe.
The ambition behind the science
Your biology has a history. Our vision is a virtual twin that evolves with you, helping connect signals across time and giving healthcare a more personal foundation.
Our medical vision grows from mass spectrometry, statistical algorithms, AI, biological profiling and work with clinical and scientific collaborators. Explore the full research landscape, then go deeper into the publications behind it.
A published foundation for exploring biological identity with human twin technology.
Read the publication ↗Institutional announcement2025Cleveland Clinic Abu Dhabi announced a pilot with BioTwin in breast cancer screening research.
Read the announcement ↗Preprint · not peer reviewed2026A retrospective case-control study exploring blood-based metabolic signals. Prospective validation remains a separate step.
Read the preprint ↗Documented clinical collaboration
Cleveland Clinic Abu DhabiA clinical collaboration announced on 31 January 2025.
Read the institutional announcement
Department of Health, Abu DhabiThe 2025 announcement records approval for the pilot for research purposes.
Read the institutional announcementDiscuss medical access, bring BioTwin to a clinical project, or start exploring your biology with a TwinMe program today.
For individuals, clinicians and research partners interested in the clinical applications of our technology and UAE pathways.
Contact BioTwinHealth optimization, longevity, weight management and Apex performance. Choose the goal that matters to you.
Compare programs & orderClinical access is currently through participating physicians in the United Arab Emirates, alongside continued validation. Contact BioTwin to discuss eligibility, current availability and the next step.
Our science and research page brings together the clinical applications in development, neurological and cardiovascular research, metabolic health, collaborators and publications.
The Cancer Risk Program focuses on wellness and risk factors. The medical decision-support pathway is accessed through clinicians in the UAE.